Your browser doesn't support javascript.
loading
Assessment of Tp-Te interval in patients with cardiac AL amyloidosis.
Tor, Yavuz B; Habibov, Ismat; Altinkaynak, Mustafa; Aydogan, Mehmet; Baykiz, Derya; Tayfur, Mehmet; Gonenli, Mehmet G; Onur, Imran; Kalayoglu-Besisik, Sevgi; Saka, Bulent; Erten, Sebile N; Akpinar, Timur S.
Afiliação
  • Tor YB; Department of Internal Medicine, Memorial Bahcelievler Hospital, Istanbul, Turkey. Email: yavuzburaktor@gmail.com.
  • Habibov I; Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Altinkaynak M; Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Aydogan M; Department of Cardiology, Bitlis Tatvan State Hospital, Bitlis, Turkey.
  • Baykiz D; Department of Cardiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Tayfur M; Department of Internal Medicine, Health Sciences University, Umraniye Training and Research Hospital, Istanbul, Turkey.
  • Gonenli MG; Department of Internal Medicine, Koc University School of Medicine, Istanbul, Turkey.
  • Onur I; Department of Internal Medicine, Memorial Bahcelievler Hospital, Istanbul, Turkey.
  • Kalayoglu-Besisik S; Division of Haematology, Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Saka B; Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Erten SN; Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
  • Akpinar TS; Department of Internal Medicine, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey.
Cardiovasc J Afr ; 34: 1-5, 2024 Jan 15.
Article em En | MEDLINE | ID: mdl-38270525
ABSTRACT

BACKGROUND:

Prolonged Tp-Te interval is strongly associated with fatal ventricular arrhythmias and mortality. This association has been demonstrated in various diseases. However, the current literature does not give any information on Tp-Te interval in cardiac amyloid light-chain (AL) amyloidosis.

METHODS:

We retrospectively screened 116 cardiac AL amyloidosis patients and 35 patients were included in the study. Demographic, laboratory, 12-lead electrocardiographic (QTc, Tp-Te V1-V6) and transthoracic echocardiographic data of the patients were analysed and compared with 35 healthy controls.

RESULTS:

QTc and Tp-Te V2-V5 were significantly prolonged in the cardiac AL amyloidosis group (p < 0.05). Also, there was a positive and statistically significant correlation between the parameters of QTc and Tp-Te V3-V6, and also between the parameters of interventricular septum thickness at enddiastole and Tp-Te V2-V5.

CONCLUSION:

We present the first strong evidence of prolonged Tp-Te intervals in patients with cardiac AL amyloidosis. There may also be a relationship between prolonged Tp-Te interval and the development of arrhythmia in this patient group, as in some other groups. There is a need for prospective studies examining the relationship of prolonged Tp-Te interval with arrhythmias and its prognostic significance in cardiac AL amyloidosis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Cardiovasc J Afr Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Cardiovasc J Afr Ano de publicação: 2024 Tipo de documento: Article